Clinical Trial Update: A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase I/II study of the protease inhibitor indinavir (MK-0639) in children with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Indinavir (indinavir)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acquired Immunodeficiency Syndrome, HIV Infections | Phase 1 | Status: COMPLETED